Dexcom Kiboshes Insulet Merger Rumors
Bloomberg reported on 23 May that Dexcom is considering acquiring Insulet to become a diabetes tech giant. Dexcom said on 31 May that it is not in “active discussions” about a merger with anyone right now.
You may also be interested in...
The company’s cash balance at the end of last quarter was more than enough to weather most storms – so why has Dexcom raised more money?
After six months, the Omnipod 5 has seen its limited market launch expanded to cover the entirety of the US market.
The major players in the diabetes tech sector announced new and re-hashed old clinical data at this year’s American Diabetes Association Scientific Sessions in New Orleans.